GlassScriptPhysician profile
Douglas Bartels
NPI 1508220187
$44,076.17
in general payments reported to CMS, 2019-2025
10 companies · $551 in 2025
The $551 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $128 · 2020: $29.80 · 2021: $20K · 2022: $23K · 2023: $188 · 2024: $553 · 2025: $551.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,292.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,292.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $21,431.66 | 2021-2022 | |
| Evolution Surgical, INC | $14,528.63 | 2021-2022 | |
| Arthrex, INC. | $5,067.16 | 2022 | |
| Stryker Corporation | $2,041.29 | 2019-2025 | Triathlon, Mako, Hoffmann |
| True North Surgical INC | $528.61 | 2022-2024 | |
| Xiros INC | $130.49 | 2022 | |
| Vericel Corporation | $111.92 | 2024 | Maci |
| Zimmer Biomet Holdings, INC. | $103.67 | 2022 | |
| Exactech, INC. | $102.94 | 2022 | |
| Depuy Synthes Sales INC. | $29.80 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Bartels listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.